Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01896518 · ClinicalTrials.gov registry record · NA
Novel Methods to Reduce Children's Secondhand Smoke Exposure II
A NA study of Secondhand Smoke, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT01896518: Completed NA study of Secondhand Smoke, sponsored by University of Oklahoma.
NCT01896518 is a NA study of Secondhand Smoke that has completed, run by University of Oklahoma. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01896518, a NA study of Secondhand Smoke, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of the current study is to determine if the use of nicotine containing products by caregivers who smoke and who are not interested in quitting, is effective in reducing children's secondhand smoke exposure.
Primary Outcome
Child salivary cotinine will be measured to assess the level of secondhand smoke exposure. We will measure the change throughout the study.
Conditions Studied
Interventions
- DRUG Nicotine polacrilex
- DRUG Tobacco lozenge
Study Locations (1)
Oklahoma
- The Children's Hospital at OU Medical Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01896518 record still lists
NCT01896518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Secondhand Smoke appearing as the primary indexed condition, and to 2 interventions - of which Nicotine polacrilex is the first listed.
NCT01896518 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01896518 about?
NCT01896518 is a clinical study titled "Novel Methods to Reduce Children's Secondhand Smoke Exposure II". The overall aim of the current study is to determine if the use of nicotine containing products by caregivers who smoke and who are not interested in quitting, is effective in reducing children's secondhand smoke exposure.
What is the current status of trial NCT01896518?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2012-11. Estimated completion is 2014-12.
What conditions does trial NCT01896518 study?
This clinical trial studies the following conditions: Secondhand Smoke.
What interventions are being tested in trial NCT01896518?
The interventions under investigation include: Nicotine polacrilex (DRUG), Tobacco lozenge (DRUG).
Who is sponsoring clinical trial NCT01896518?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01896518 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Secondhand Smoke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01896518's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia